11/08/24 | 2:56 pm

Print

MEA and NSIL sign MoU for grant assistance for the launch of Munal satellite

An MoU was signed between the Ministry of External Affairs, Government of India and NewSpace India Limited (NSIL) today for grant assistance for the launch of Nepal’s Munal satellite.

The MoU was signed by Anurag Srivastava, JS (North) from MEA and Shri Arunachalam A, Director from NSIL. Dr. Rabindra Prasad Dhakal, Secretary, Nepal Academy of Science and Technology (NAST), Dr. Surendra Thapa, Chargé d’affaires of Nepali Embassy and Dr. Abhas Maskey, Founder, Antarikchya Pratishan Nepal (APN) were also present at the occasion.

During the visit of External Affairs Minister to Nepal to co-chair the 7th JCM meeting, EAM witnessed the exchange of this Launch Service Agreement for the launch of Munal Satellite between NSIL and NAST, on 04 January 2024.

Munal Satellite is an indigenous satellite developed in Nepal, under the aegis of NAST. APN, a Nepali space startup, has assisted Nepali students in the design and fabrication of this satellite. The satellite aims to build a vegetation density database of the Earth’s surface.

This satellite is expected to be launched soon on NSIL’s Polar Satellite Launch Vehicle.

By: Sweta Singh (Kathmandu)

RELATED ARTICLES

17 mins ago | 4th India-Japan Foreign and Defence Ministers Meeting

Rajnath Singh receives ceremonial guard of honour at Japan’s Defence Ministry in Tokyo

Defence Minister Rajnath Singh arrived at the Ministry of Defence in Tokyo on Wednesday, where he was received by his Japanese counterpart, Shinjiro Koizumi. Upon his arrival at the Ministry, Singh was accorded a ceremonial guard of honour. The Def...

18 mins ago | APEC summit

Xi, Putin blast Western ‘protectionism’, sanctions before meeting Trump at APEC

China's President Xi Jinping on Wednesday pledged to stand up against trade protectionism, while his Russian counterpart Vladimir Putin criticised Western sanctions as the two set the stage for a high-stakes trilateral meeting with Donald Trump. The...

29 mins ago | Biocon gets European Commission nod

Biocon gets European Commission nod for breast cancer biosimilar Pebrilzo

Biopharmaceutical firm Biocon Ltd has received marketing authorisation from the European Commission (EC) for Pebrilzo, its pertuzumab biosimilar, to treat HER2-positive breast cancer across multiple disease stages in the European Union. Biocon's per...